Revolo Biotherapeutics is developing revolutionary therapies powered to reset the immune system to achieve superior long-term remission for patients with autoimmune & allergic diseases, while preventing the unwanted effects of chronic immune suppression.
Location: United States, Louisiana, New Orleans
Employees: 11-50
Total raised: $126.364212M
Founded date: 2011
Investors 4
| Date | Name | Website |
| 10.09.2022 | NCL Techno... | ncltv.co.u... |
| - | 24Haymarke... | 24haymarke... |
| - | NCL Invest... | nclim.co.u... |
| - | Greenwood ... | gwcinvesto... |
Funding Rounds 3
| Date | Series | Amount | Investors | Deal News |
| 06.10.2020 | Series B | $71.5M | 24Haymarke... | - |
| 21.09.2020 | Series B | $54M | - | gwcinvesto... |
| 21.06.2020 | - | $864.212K | - | gwcinvesto... |
Mentions in press and media 10
| Date | Title | Description | Source |
| 07.10.2021 | AI-Driven PROVEN Skincare Announces Launch of $60 Million Re... | PROVEN Skincare (“PROVEN” or the “Company”), an AI-powered, technology first consumer company that f... | marketscre... |
| 05.10.2021 | Stealth BioTherapeutics : Completes a $25 Million Debt Finan... | BOSTON - Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused... | marketscre... |
| 06.10.2020 | A2 Biotherapeutics : Closes $71.5M Series B to Begin Clinica... | A2 Biotherapeutics (www.a2bio.com), a biotechnology company developing innovative cell therapies for... | marketscre... |
| 23.09.2020 | Immune Regulation lands $53.4M Series B | Morningside Ventures has led a $53.4 million investment in Immune Regulation, with support from inve... | pitchbook.... |
| 23.09.2020 | SBC occupier Immune Regulation Limited raises £40.6 million ... | SBC occupier Immune Regulation Limited raises £40.6 million Series B equity financing 23-09-2020 S... | cambridgen... |
| 21.09.2020 | Immune Regulation Raises £40.6M in Series B Equity Financing... | Immune Regulation Limited, a US and UK based clinical stage biotechnology company, closed a $40.6m S... | finsmes.co... |
| 21.09.2020 | Immune Regulation raises $53m Series B round led by Mornings... | - | 24haymarke... |
| 21.09.2020 | Morningside ventures invests $54m in Immune Regulation, a GW... | Series B round led by Morningside Ventures provides foundation to accelerate the drug development of... | gwcinvesto... |
| 21.06.2020 | GWC members invest £700k in Immune Regulation | Immune Regulation is a clinical stage biotech company, pioneering new technologies for resetting the... | gwcinvesto... |
| 22.11.2018 | 24Haymarket co-leads £4m investment in Immune Regulation | - | 24haymarke... |